1. Home
  2. ELVN vs HFWA Comparison

ELVN vs HFWA Comparison

Compare ELVN & HFWA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELVN
  • HFWA
  • Stock Information
  • Founded
  • ELVN 2016
  • HFWA 1927
  • Country
  • ELVN United States
  • HFWA United States
  • Employees
  • ELVN N/A
  • HFWA N/A
  • Industry
  • ELVN Biotechnology: Pharmaceutical Preparations
  • HFWA Banks
  • Sector
  • ELVN Health Care
  • HFWA Finance
  • Exchange
  • ELVN Nasdaq
  • HFWA Nasdaq
  • Market Cap
  • ELVN 927.8M
  • HFWA 843.8M
  • IPO Year
  • ELVN 2020
  • HFWA N/A
  • Fundamental
  • Price
  • ELVN $21.30
  • HFWA $22.57
  • Analyst Decision
  • ELVN Strong Buy
  • HFWA Hold
  • Analyst Count
  • ELVN 5
  • HFWA 3
  • Target Price
  • ELVN $39.60
  • HFWA $27.67
  • AVG Volume (30 Days)
  • ELVN 594.3K
  • HFWA 170.7K
  • Earning Date
  • ELVN 08-12-2025
  • HFWA 07-24-2025
  • Dividend Yield
  • ELVN N/A
  • HFWA 4.25%
  • EPS Growth
  • ELVN N/A
  • HFWA 11.50
  • EPS
  • ELVN N/A
  • HFWA 1.48
  • Revenue
  • ELVN N/A
  • HFWA $220,859,000.00
  • Revenue This Year
  • ELVN N/A
  • HFWA $23.49
  • Revenue Next Year
  • ELVN N/A
  • HFWA $7.68
  • P/E Ratio
  • ELVN N/A
  • HFWA $15.22
  • Revenue Growth
  • ELVN N/A
  • HFWA 0.16
  • 52 Week Low
  • ELVN $13.30
  • HFWA $16.69
  • 52 Week High
  • ELVN $30.03
  • HFWA $27.58
  • Technical
  • Relative Strength Index (RSI)
  • ELVN 55.53
  • HFWA 42.55
  • Support Level
  • ELVN $18.53
  • HFWA $22.27
  • Resistance Level
  • ELVN $24.11
  • HFWA $22.92
  • Average True Range (ATR)
  • ELVN 1.96
  • HFWA 0.52
  • MACD
  • ELVN 0.15
  • HFWA -0.11
  • Stochastic Oscillator
  • ELVN 55.68
  • HFWA 17.54

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.

About HFWA Heritage Financial Corporation

Heritage Financial Corp is a bank holding company. The company through its subsidiary provides commercial lending and deposit relationships with small businesses and their owners in its market areas and attracts deposits from the general public. It accepts various deposit products, such as noninterest demand accounts, money market accounts, savings accounts, and certificates of deposit. Besides, the Bank also makes real estate construction loans, land development loans, and consumer loans, and originates first mortgage loans on residential properties mainly located in its market area. Geographically, all the business activity functions through the region of the United States.

Share on Social Networks: